PhD
Dr. Raphela Aranie Ranjan is a postdoctoral researcher at the Technical University of Munich, Germany, with over a decade of experience in biomedical and cancer research. Her expertise lies in 3D cancer models and in ovo systems, emphasizing tumor biology, stromal remodeling, and metastasis.She has demonstrated excellence in scientific communication, manuscript preparation, and project management, contributing to peer-reviewed publications and international conference presentations. Dr. Ranjan completed her PhD magna cum laude and has cultivated a research philosophy rooted in collaboration, clarity, and translational impact.
Presented multiple posters and oral talks at international conferences (e.g., ISMRM, EASL, DPC, EMIM, AACR)
Mentored junior researchers and students in manuscript preparation and data presentation
Contributed abstracts to major cancer and imaging conferences (2020–2025)
Reviewer and editor for scientific manuscripts (as part of postdoctoral and editorial roles)
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer. Cancers (2023), 15, 1704.
Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. Gastroenterology (2021), 160:346–385.
Implementing Cell-Free DNA of Pancreatic Cancer Patient-Derived Organoids for Personalized Oncology. JCI Insight (2020), 5(15): e137809.
